Your browser doesn't support javascript.
loading
Survival and New Prognosticators in Metastatic Seminoma: Results From the IGCCCG-Update Consortium.
Beyer, Jörg; Collette, Laurence; Sauvé, Nicolas; Daugaard, Gedske; Feldman, Darren R; Tandstad, Torgrim; Tryakin, Alexey; Stahl, Olof; Gonzalez-Billalabeitia, Enrique; De Giorgi, Ugo; Culine, Stéphane; de Wit, Ronald; Hansen, Aaron R; Bebek, Marko; Terbuch, Angelika; Albany, Costantine; Hentrich, Marcus; Gietema, Jourik A; Negaard, Helene; Huddart, Robert A; Lorch, Anja; Cafferty, Fay H; Heng, Daniel Y C; Sweeney, Christopher J; Winquist, Eric; Chovanec, Michal; Fankhauser, Christian; Stark, Daniel; Grimison, Peter; Necchi, Andrea; Tran, Ben; Heidenreich, Axel; Shamash, Jonathan; Sternberg, Cora N; Vaughn, David J; Duran, Ignacio; Bokemeyer, Carsten; Patrikidou, Anna; Cathomas, Richard; Assele, Samson; Gillessen, Silke.
Affiliation
  • Beyer J; Department of Medical Oncology, Inselspital, University Hospital, University of Bern, Bern, Switzerland.
  • Collette L; European Organisation for Research and Treatment of Cancer, Brussels, Belgium.
  • Sauvé N; European Organisation for Research and Treatment of Cancer, Brussels, Belgium.
  • Daugaard G; Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
  • Feldman DR; Memorial Sloan Kettering Cancer Center, New York, NY.
  • Tandstad T; Weill Medical College of Cornell University, New York, NY.
  • Tryakin A; The Cancer Clinic, St Olavs University Hospital and Department of Clinical and Molecular Medicine, The Norwegian University of Science and Technology, Trondheim, Norway.
  • Stahl O; N.N. Blokhin Russian Cancer Research Center, Moscow, Russian Federation.
  • Gonzalez-Billalabeitia E; Research Institute of Oncology at Bashkir State Medical University, Ufa, Russian Federation.
  • De Giorgi U; Department of Oncology, Skåne University Hospital, Lund, Sweden.
  • Culine S; Servicio de Oncologia Medica, Hospital Universitario 12 de Octubre, Madrid, Spain.
  • de Wit R; Universidad Catolica San Antonio de Murcia, UCAM, Murcia, Spain.
  • Hansen AR; Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy and the Italian Germ Cell Cancer Group (IGG), Italy.
  • Bebek M; Department of Medical Oncology, Hôpital Saint-Louis, AP-HP, Faculté de Paris, Paris, France.
  • Terbuch A; Erasmus MC Cancer Institute, Rotterdam, the Netherlands.
  • Albany C; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.
  • Hentrich M; Department of Oncology, University Hospital Centre Zagreb, Zagreb, Croatia.
  • Gietema JA; Division of Oncology, Department of Internal Medicine, Medical University of Graz, Graz, Austria.
  • Negaard H; Indiana University Melvin and Bren Simon Cancer Center, Indianapolis, IN.
  • Huddart RA; Department of Hematology and Oncology, Red Cross Hospital, University of Munich, Munich, Germany.
  • Lorch A; University Medical Center Groningen, Groningen, the Netherlands.
  • Cafferty FH; Department of Oncology, Oslo University Hospital, Oslo, Norway.
  • Heng DYC; Institute of Cancer Research, Sutton, United Kingdom.
  • Sweeney CJ; Department of Medical Oncology and Hematology, University Hospital Zurich, Zurich, Switzerland.
  • Winquist E; Department of Urology, University Hospital Dusseldorf, Dusseldorf, Germany.
  • Chovanec M; Medical Research Council Clinical Trials Unit at University College London (UCL), London, United Kingdom.
  • Fankhauser C; Tom Baker Cancer Centre, University of Calgary, Calgary, Alberta, Canada.
  • Stark D; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.
  • Grimison P; Division of Medical Oncology, Western University and London Health Sciences Centre, London, Ontario, Canada.
  • Necchi A; 2nd Department of Oncology, Faculty of Medicine, Comenius University and National Cancer Institute, Bratislava, Slovakia.
  • Tran B; University of Zurich, Zurich, Switzerland.
  • Heidenreich A; Leeds Institute of Medical Research, University of Leeds, Leeds, United Kingdom.
  • Shamash J; Australian and New Zealand Urogenital and Prostate Cancer Trials Group, Sydney, Australia.
  • Sternberg CN; Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. Current affiliation: Vita-Salute San Raffaele University and IRCCS San Raffaele Hospital and Scientific Institute, Milan, Italy.
  • Vaughn DJ; Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Australia.
  • Duran I; Department of Urology, Uro-Oncology, Robot-Assisted and Specialized Urologic Surgery, University Hospital Cologne, Cologne, Germany.
  • Bokemeyer C; St Bartholomew's Hospital, London, United Kingdom.
  • Patrikidou A; Medical Oncology, San Camillo Forlanini Hospital, Rome, Italy. Current affiliation: Englander Institute for Precision Medicine, Weill Cornell Medicine, New York-Presbyterian, New York, NY.
  • Cathomas R; University of Pennsylvania, Philadelphia, PA.
  • Assele S; Hospital Universitario Marques de Valdecilla and IDIVAL, Santander, Spain.
  • Gillessen S; Department of Oncology, Hematology and BMT with Section Pneumology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
J Clin Oncol ; 39(14): 1553-1562, 2021 05 10.
Article in En | MEDLINE | ID: mdl-33729863
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Health context: 6_ODS3_enfermedades_notrasmisibles Database: MEDLINE Main subject: Testicular Neoplasms / Seminoma Type of study: Clinical_trials / Prognostic_studies Limits: Humans / Male Language: En Journal: J Clin Oncol Year: 2021 Document type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Health context: 6_ODS3_enfermedades_notrasmisibles Database: MEDLINE Main subject: Testicular Neoplasms / Seminoma Type of study: Clinical_trials / Prognostic_studies Limits: Humans / Male Language: En Journal: J Clin Oncol Year: 2021 Document type: Article